New Eye Drop Treatment for Diabetic Retinopathy to Begin Advanced Testing
Exonate, a pharmaceutical company, has announced plans to start a phase 2b clinical trial for its lead drug, EXN407, in […]
Browsing category
Exonate, a pharmaceutical company, has announced plans to start a phase 2b clinical trial for its lead drug, EXN407, in […]
Dr. George Tidmarsh, a physician, academic, and biotech entrepreneur, has been appointed as the new director of the FDA’s Center […]
AstraZeneca has received a positive recommendation from NICE (the National Institute for Health and Care Excellence) for a new combination […]
President Donald Trump has warned 17 major drug companies that they must lower their prices to match those in other […]
President Trump has sent letters to major drug companies, urging them to lower prices in the U.S. to match the […]
4TEEN4 Pharmaceuticals has started testing a new drug called procizumab in patients with cardiogenic shock, a life-threatening condition where the […]
A new £4.8 billion ($6.45 billion) free trade agreement (FTA) between the UK and India is expected to create new […]
After a slow recovery in 2024, biotech companies looking to go public in 2025 may face more obstacles. While only […]
TCG Labs Soleil, a company that creates focused biotechnology startups and prepares them for partnerships, announced on Thursday that it […]
The European Medicines Agency (EMA) has recommended against approving Sarepta’s gene therapy, Elevidys, for Duchenne muscular dystrophy (DMD) after a […]